Since its IPO, Compass Therapeutics has been fairly volatile. From it's Covid lows, it had quite a run, gaining over 300% in a fairly short amount of time. There was heavy insider buying and very little short interest. This happened all while the overall market and indices were making the 2022 lows. It has since been on a steep downward trajectory, and I have...
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that,...